SPRY · Healthcare · $421M
After-hours $4.33+0.46%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출이 2025년 4분기 2,800만 달러, 2026년 1분기 2,300만 달러로 둔화됐다가 이번 분기 3,370만 달러로 반등했어요.”
In the company's words · 2026 2분기 earnings call